Overview

An Open-Label Study To Assess The Pharmacokinetics, Safety And Toleration Of Vfend®; Following Multiple Dosing With Vfend

Status:
Terminated
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
This is a study to investigate the pharmacokinetics, safety and tolerability of intravenous voriconazole and SBECD in patients with moderate renal insufficiency
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Voriconazole